Iris Levink (@ilevink) 's Twitter Profile
Iris Levink

@ilevink

ID: 1562493553338888193

calendar_today24-08-2022 17:34:40

146 Tweet

129 Followers

151 Following

UEGJ (@uegjournal) 's Twitter Profile Photo

Check our latest Podcast ✴️ 🚨In this episode:  Tarik  interviews @a_zanetto discussing their new study which introduced a new model to predict acute decompensation in patients with liver cirrhosis. 🔗 open.spotify.com/episode/68PYIP… 🔗 to manuscript onlinelibrary.wiley.com/doi/10.1002/ue…

Check our latest Podcast ✴️

🚨In this episode:  <a href="/htkani/">Tarik</a>  interviews @a_zanetto discussing their new study which introduced a new model to predict acute decompensation in patients with liver cirrhosis.

🔗 open.spotify.com/episode/68PYIP…

🔗 to manuscript

onlinelibrary.wiley.com/doi/10.1002/ue…
Joost PH Drenth (@joostphdrenth) 's Twitter Profile Photo

Iris Levink takes a “juicy “ view of #pancreaticcancer 🧐Zeroing in on biomarkers 🎯 The infamous Ca19.9 📢 message elevated if cancer but doesn’t distinguish between early stages ✌️Kudos for this superb PhD thesis Erasmus MC Intl Giovanni Marchegiani onlinelibrary.wiley.com/doi/10.1002/ue…

UEGJ (@uegjournal) 's Twitter Profile Photo

🆕Review Article 📊MASLD is on the rise 🧬Genetic variants help stratify risk ✔️Genetic-based tools diagnose and predict MASLD outcomes ✴️Current tools lack optimal accuracy 🤖AI could enhance decision-making algorithms in MASLD treatment doi.org/10.1002/ueg2.1…

🆕Review Article
📊MASLD is on the rise
🧬Genetic variants help stratify risk
✔️Genetic-based tools diagnose and predict MASLD outcomes
✴️Current tools lack optimal accuracy
🤖AI could enhance decision-making algorithms in MASLD treatment

doi.org/10.1002/ueg2.1…
UEGJ (@uegjournal) 's Twitter Profile Photo

⬆️ Compliance: H. pylori eradication treatment has a 98.3% adherence ⬇️ Compliance: Linked to dyspepsia, rescue treatments, longer prescriptions, adverse events, and complex therapies ✴️ Success Correlation: Adherence is key to successful eradication doi.org/10.1002/ueg2.1…

⬆️ Compliance: H. pylori eradication treatment has a 98.3% adherence

⬇️ Compliance: Linked to dyspepsia, rescue treatments, longer prescriptions, adverse events, and complex therapies

✴️ Success Correlation: Adherence is key to successful eradication

doi.org/10.1002/ueg2.1…
irenemarafini (@irenemarafini) 's Twitter Profile Photo

Hey Y-ECCO #EHMSG ESGE 🥇What makes a high-quality clinical guideline? 🏥Do you use guidelines in your practice? 🤝What earns a guideline your trust? 4 weeks to go!!

Hey <a href="/Y_ECCO_IBD/">Y-ECCO</a> <a href="/ehmsg/">#EHMSG</a> <a href="/ESGE_news/">ESGE</a> 
🥇What makes a high-quality clinical guideline?
🏥Do you use guidelines in your practice?
 🤝What earns a guideline your trust?

4 weeks to go!!
my_UEG (@my_ueg) 's Twitter Profile Photo

UEGJ editors want to get your view of what constitutes high-quality guidelines! Please take part in this survey: bit.ly/4aszKGt #myUEGcommunity #weareUEG #UEGJ

<a href="/UEGJournal/">UEGJ</a> editors want to get your view of what constitutes high-quality guidelines!

Please take part in this survey: bit.ly/4aszKGt

#myUEGcommunity #weareUEG #UEGJ
UEGJ (@uegjournal) 's Twitter Profile Photo

✴️ 43.6% of fecal VOCs decreased in Crohn's (CD) or ulcerative colitis (UC). 📊 Oct-1-en-3-ol rose in CD and UC, then fell in UC with treatment. 💩Fecal VOCs aid non-invasive IBD diagnosis Wiley Clinical Health my_UEG Joost PH Drenth doi.org/10.1002/ueg2.1…

✴️ 43.6% of fecal VOCs decreased in Crohn's (CD) or ulcerative colitis (UC).

📊 Oct-1-en-3-ol rose in CD and UC, then fell in UC with treatment.

💩Fecal VOCs aid non-invasive IBD diagnosis

<a href="/WileyHealth/">Wiley Clinical Health</a> <a href="/my_ueg/">my_UEG</a> <a href="/joostphdrenth/">Joost PH Drenth</a> 

doi.org/10.1002/ueg2.1…
my_UEG (@my_ueg) 's Twitter Profile Photo

Are you a clinical scientist looking to get your research seen by a wider audience? 💡 Submit your work to UEGJ & share your findings with digestive healthcare professionals around the world. 🔗 Find out more: bit.ly/3OoWizy #myUEGcommunity #weareUEG #UEGJ

Are you a clinical scientist looking to get your research seen by a wider audience? 💡 Submit your work to <a href="/uegjournal/">UEGJ</a> &amp; share your findings with digestive healthcare professionals around the world. 

🔗 Find out more: bit.ly/3OoWizy 
#myUEGcommunity #weareUEG #UEGJ
UEGJ (@uegjournal) 's Twitter Profile Photo

🆕 in UEG Journal Prospective 24 week study included 24 patients No incidence of spondylarthritis in either tumor necrosis factor inhibitor alpha naïve or experienced patients occurred after initiating vedolizumab Wiley Clinical Health my_UEG Joost PH Drenth doi.org/10.1002/ueg2.1…

🆕 in UEG Journal 

Prospective 24 week study included 24 patients 

No incidence of spondylarthritis in either tumor necrosis factor inhibitor alpha naïve or experienced patients occurred after initiating vedolizumab

<a href="/WileyHealth/">Wiley Clinical Health</a> <a href="/my_ueg/">my_UEG</a> <a href="/joostphdrenth/">Joost PH Drenth</a> 

doi.org/10.1002/ueg2.1…
Lumír Kunovský (@lumirkunovsky) 's Twitter Profile Photo

🟢 Join ➡️ my_UEG and 🔴 discover our 🔝 premier 👑 UEG Journal ➡️ UEGJ ❗️ 📕 publish in UEGJ 🥰 👉tinyurl.com/yexhmkpr my_UEG🟢 YOUPPIE Pancreas🟠 Y-ECCO🟣 Wiley Clinical Health🔵 #UEGWeek 2️⃣0️⃣2️⃣4️⃣ 🇦🇹 #Vienna 🎡 #myUEGcommunity 🟢 #GITwitter 🔴

🟢 Join ➡️  <a href="/my_ueg/">my_UEG</a> and 
🔴 discover our 🔝 premier 👑 UEG Journal  ➡️ <a href="/UEGJournal/">UEGJ</a> ❗️

📕 publish in <a href="/UEGJournal/">UEGJ</a> 🥰
👉tinyurl.com/yexhmkpr

<a href="/my_ueg/">my_UEG</a>🟢
<a href="/YouppiePancreas/">YOUPPIE Pancreas</a>🟠
<a href="/Y_ECCO_IBD/">Y-ECCO</a>🟣
<a href="/WileyHealth/">Wiley Clinical Health</a>🔵

#UEGWeek 2️⃣0️⃣2️⃣4️⃣ 🇦🇹
#Vienna 🎡
#myUEGcommunity 🟢
#GITwitter 🔴